Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Apr 14;16(4):e0250084. doi: 10.1371/journal.pone.0250084

Genomic and phenotypic diversity of Enterococcus faecalis isolated from endophthalmitis

Gayatri Shankar Chilambi 1, Hayley R Nordstrom 1, Daniel R Evans 1, Regis P Kowalski 2, Deepinder K Dhaliwal 2, Vishal Jhanji 2, Robert M Q Shanks 2, Daria Van Tyne 1,*
Editor: Iddya Karunasagar3
PMCID: PMC8046195  PMID: 33852628

Abstract

Enterococcus faecalis are hospital-associated opportunistic pathogens and also causative agents of post-operative endophthalmitis. Patients with enterococcal endophthalmitis often have poor visual outcomes, despite appropriate antibiotic therapy. Here we investigated the genomic and phenotypic characteristics of E. faecalis isolates collected from 13 patients treated at the University of Pittsburgh Medical Center Eye Center over 19 years. Comparative genomic analysis indicated that patients were infected with E. faecalis belonging to diverse multi-locus sequence types (STs) and resembled E. faecalis sampled from clinical, commensal, and environmental sources. We identified known E. faecalis virulence factors and antibiotic resistance genes in each genome, including genes conferring resistance to aminoglycosides, erythromycin, and tetracyclines. We assessed all isolates for their cytolysin production, biofilm formation, and antibiotic susceptibility, and observed phenotypic differences between isolates. Fluoroquinolone and cephalosporin susceptibilities were particularly variable between isolates, as were biofilm formation and cytolysin production. In addition, we found evidence of E. faecalis adaptation during recurrent endophthalmitis by identifying genetic variants that arose in sequential isolates sampled over eight months from the same patient. We identified a mutation in the DNA mismatch repair gene mutS that was associated with an increased rate of spontaneous mutation in the final isolate from the patient. Overall this study documents the genomic and phenotypic variability among E. faecalis causing endophthalmitis, as well as possible adaptive mechanisms underlying bacterial persistence during recurrent ocular infection.

Introduction

Enterococci are Gram-positive bacteria that inhabit the gastrointestinal tract of humans and other land animals [1]. Enterococci also cause a wide variety of infections, particularly in immunocompromised hosts. Two members of the Enterococcus genus, E. faecium and E. faecalis, account for nearly 75% of all enterococcal infections [2]. Multidrug-resistant E. faecalis are leading causes of healthcare-associated infections, including bacteremia, endocarditis, and urinary tract, intra-abdominal, surgical site, and device-associated infections [3]. The prevalence of enterococci in the modern hospital environment is attributed to their intrinsic resistance to commonly used antibiotics, their ability to survive under harsh and stressful conditions, their propensity to acquire mobile genetic elements carrying drug resistance and other pathogenicity-enhancing genes, and their ability to form biofilms on indwelling medical devices such as catheters and intraocular lenses [46].

Endophthalmitis is characterized by inflammation of the interior of the eye. It is often caused by infection, either as a consequence of intraocular surgery (post-operative endophthalmitis), penetrating injury (post-traumatic endophthalmitis), or spread of bacteria from a distant site of infection to the eye (endogenous endophthalmitis) [7]. Most cases of bacterial endophthalmitis are caused by coagulase-negative staphylococci (CoNS), Staphylococcus aureus and viridans group streptococci [8]. E. faecalis are infrequently isolated from post-operative endophthalmitis, but patients with post-operative enterococcal endophthalmitis have worse clinical outcomes compared with similar infections caused by CoNS and S. aureus [9]. The increasing occurrence of E. faecalis as a causative organism of post-operative endophthalmitis has been reported across the world [1012].

The purpose of this study was to characterize the genomic and phenotypic features of 15 E. faecalis isolates from post-operative endophthalmitis collected from 13 patients treated at the University of Pittsburgh Medical Center (UPMC) Eye Center. In addition to assessing the genomic diversity of these isolates, we also analyzed their plasmid, antibiotic resistance gene, CRISPR-Cas, prophage and virulence gene profiles. We measured the susceptibility of each isolate to antibiotics commonly used to treat enterococcal endophthalmitis, as well as their ability to produce the cytolysin toxin and form biofilms. Where possible, we made connections between these phenotypes and bacterial genotypes. Finally, we identified factors contributing to the persistent colonization of E. faecalis in one patient with recurrent endophthalmitis [13].

Methods

Collection of isolates

Bacterial isolates were collected from patients seeking treatment at the UPMC Eye Center between 1993 and 2012. The clinical specimens were processed in the Charles T. Campbell Ophthalmic Microbiology Laboratory, University of Pittsburgh Medical Center, Pittsburgh, PA. In general, samples of aqueous and vitreous humor of patients with endophthalmitis were cultured for pathogens. The specimens were collected directly by tapping eye chambers using tuberculin syringes and needles. An approximate volume of 0.2–0.3 mL of intraocular fluid was collected from each patient. Intraocular fluid was placed on two glass slides for rapid visualization of microorganisms using Gram and Giemsa staining. The remaining fluid was dispersed on various isolation medium, including trypticase soy agar supplemented with 5% sheep blood, chocolate agar, enriched thioglycolate broth, a chocolate agar plate incubated in an anaerobic bag, and Sabouraud dextrose medium with gentamicin for fungal detection. Most aerobic plates were incubated at 37°C in a CO2 atmosphere. The Sabouraud dextrose medium was incubated in a 30°C air incubator. Enterococcus faecalis grew readily on all culture media. The isolates were Gram-positive cocci (coccoidal), catalase-negative, pyrrolidonyl arylamidase-positive, and colonies were greyish in nature. After laboratory isolation, E. faecalis isolates were patient de-identified, and were stored at -80°C in broth medium containing 15% glycerol. Isolates were saved as part of a clinical tissue bank used for testing and antimicrobial susceptibility validation. The study was approved by the University of Pittsburgh Institutional Review Board under protocol number STUDY19110081.

Whole genome sequencing and analysis

Genomic DNA from 15 post-operative endopthalmitis isolates was extracted using a DNeasy Blood and Tissue Kit (Qiagen, Germantown, MD) from 1mL bacterial cultures grown in Brain Heart Infusion (BHI) media. Next-generation sequencing libraries were prepared with a Nextera XT kit (Illumina, San Diego, CA), and libraries were sequenced on an Illumina MiSeq using 300bp paired-end reads. Genomes were assembled with SPAdes v3.13.0 [14], annotated with prokka [15], and were compared to one another with Roary [16]. Genome assemblies of additional E. faecalis from endophthalmitis (n = 2) and other sources (n = 49) were downloaded from the NCBI database (see S1 and S2 Tables). Core genome phylogenetic trees were generated using RAxML with the GTRCAT substitution model and 100 iterations [17]. Sequence types, antimicrobial resistance genes, virulence factors, and plasmid replicons were identified using online tools provided by the Center for Genomic Epidemiology (https://cge.cbs.dtu.dk/). CRISPR-cas loci and prophage sequences were identified using CRISPRCasFinder [18] and PHASTER (PHAge Search Tool Enhanced Release), respectively [19]. Variants were identified in serial isolates from the same patient using CLC Genomics Workbench v11.0.1 (Qiagen, Germantown, MD), using a read depth cut-off of 10 reads and a variant frequency cut-off of >90%. Illumina read data for isolates newly sequenced in this study have been submitted to NCBI under BioProject PRJNA649986, with accession numbers listed in S1 Table.

Antimicrobial susceptibility testing

Susceptibility testing to determine the minimum inhibitory concentration (MIC) of amikacin, benzalkonium chloride, ceftazidime, moxifloxacin, ofloxacin, povidone-iodine and vancomycin was carried out by broth microdilution in Mueller Hinton Broth (MHB) [20]. Briefly, overnight cultures of E. faecalis grown in MHB were diluted to an OD600 of 0.1, and were further diluted 1:1000 into fresh MHB. 100μL of this culture was then transferred to 96-well plates containing 100μL of MHB with serial two-fold dilutions of each antimicrobial, yielding approximately 105 bacteria per well. Plates were incubated for 24 hours at 37°C under static conditions, and growth in each well was analyzed by both visual inspection and by OD600 measurement using a Synergy H1 microplate reader (Biotek, Winooski, VT). Assays were conducted in triplicate and resistance was assessed according to criteria established by the Clinical and Laboratory Standards Institute [21].

Biofilm assay

Microtiter plate-based biofilm assays were performed as previously described [22]. Briefly, overnight cultures of each isolate were diluted 100-fold into BHI broth supplemented with 0.25% glucose. 200μL of each culture was plated into eight replicate wells of a 96-well untreated polystyrene microtiter plate, and plates were incubated for 24 hours at 37°C under static conditions. Planktonic cells were removed and plates were washed three times with 250μL 1xPBS, then wells were stained with 200μL 0.1% crystal violet (CV) in water. After incubation for 30 minutes at 4°C, stained wells were washed twice with 250μL 1xPBS to remove excess stain. Plates were dried and then 250μL of 4:1 ethanol:acetone was added to each well to solubilize CV-stained biofilms. After incubation for 45 minutes at room temperature, the absorbance in each well was measured at 550nm using a Synergy H1 microplate reader (Biotek, Winooski, VT). Negative control (NC) wells contained 200μL of BHI broth supplemented with 0.25% glucose and no bacteria. To compare biofilm growth with stationary phase cell density, the assay was repeated as described above, however after 24 hours of incubation at 37°C under static conditions each well was resuspended and the optical density at 600nm was recorded.

Cytolysin activity

The beta-hemolytic activity of the 15 UPMC endophthalmitis isolates was evaluated by streaking each isolate on BHI agar supplemented with 5% defibrinated horse blood. Plates were incubated for 24 hours at 37°C. A clear zone around the streaked bacteria was recorded as positive for beta-hemolysis.

Quantification of spontaneous mutation rate

The rates of spontaneous mutation in the E616, E623, and E633 isolates were determined by a previously described protocol [23]. Briefly, 50μL of overnight bacterial culture grown in BHI media was plated onto BHI agar plates, each containing 50μg/mL of rifampin. The initial cell concentration was determined by plating serial dilutions of the overnight culture onto agar with no antibiotic. Colonies were counted after overnight incubation at 37°C. The mutation frequency (μ) was determined by dividing the number of rifampin-resistant colonies on each plate by the initial inoculum.

Statistics

Differences in antimicrobial resistance gene content, biofilm formation, and spontaneous mutation rates were assessed with a two-tailed t-test.

Results

Clinical presentation and management of patients with enterococcal endophthalmitis, and identification of E. faecalis

All 13 patients in the study were examined and treated by the Retina Service at the UPMC Eye Center. The mean age of the patients was 92.5 years (range 83–99 years). All patients presented with acute endophthalmitis. The presenting visual acuity was hand motion or less in all patients. Bacterial isolates were collected as part of routine clinical care. Vitreous and aqueous humor samples were collected during surgery and were sent to the Charles T. Campbell Ophthalmic Microbiology Laboratory for bacterial isolation. Clinical management was in the form of vitrectomy and injection of intravitreal antibiotics. The final visual acuity was hand motion or less in all patients.

Genomic features of E. faecalis from endophthalmitis

A total of 15 E. faecalis isolates collected from 13 endophthalmitis patients treated at the UPMC Eye Center were available for genome sequencing and analysis. A search of the National Center for Biotechnology Information (NCBI) database identified two additional genomes isolated from patients with endophthalmitis in Denmark (Genbank accessions GCA_900205805.1 and GCA_900205785.1) [24], resulting in 17 genomes total. All isolates were sequenced on the Illumina platform, and the data were used to construct a core genome phylogeny (Fig 1). In silico multi-locus sequence typing (MLST) of all 17 genomes showed that 11 distinct sequence types (STs) were identified. No single ST was found to dominate; however, multiple isolates belonging to ST2, ST40, ST64, and ST122 were observed. In the case of the ST122 isolates, all three isolates were collected from a single patient with recurrent endophthalmitis [13]. To compare the 17 E. faecalis endophthalmitis genomes with other non-ophthalmic isolates, we also constructed a phylogeny including 49 diverse E. faecalis genomes sampled from clinical, commensal, and environmental sources [25] (S1 Fig). The endophthalmitis isolates were dispersed throughout the phylogenetic tree, confirming that no single genetic lineage was dominant among the ocular E. faecalis that we sampled.

Fig 1. Core genome phylogeny of E. faecalis endophthalmitis isolates.

Fig 1

Single-copy core genome phylogeny of 15 UPMC Campbell Lab isolates plus two additional genomes from NCBI (WGS406 and WGS410), all isolated from endophthalmitis. The RAxML tree is built from single nucleotide polymorphisms (SNPs) in 2024 single copy core genes identified with Roary. Tips are annotated with isolate name, multi-locus sequence type (ST), drug resistance-associated genes, plasmid rep genes, cytolysin operon presence, CRISPR-cas loci presence, and prophage abundance in each genome. CRISR-cas-positive isolates had Class 1 and/or Class 2 Cas proteins associated with their CRISPR loci. Intact or questionable prophages were identified with PHASTER. erm(B) = erythromycin resistance, tet(M) and tet(S) = tetracycline resistance, ant(6)-Ia, aph(3′)-III and aac(6’)-aph(2″) = aminoglycoside resistance.

We screened all 17 E. faecalis endophthalmitis genomes for acquired antimicrobial resistance genes using the ResFinder tool available through the Center for Genomic Epidemiology (CGE) [26] (Fig 1). All isolates were predicted to be intrinsically resistant to lincosamides due to the presence of lsa(A), a core gene found in all E. faecalis. Additionally, five isolates carried the erythromycin resistance gene erm(B), and eight isolates possessed either tet(M) or tet(S) tetracycline resistance genes. Finally, aminoglycoside resistance-conferring genes ant(6)-Ia and aph(3′)-III were identified in the two ST2 isolates, and aac(6’)-aph(2″) was observed in the single ST103 isolate genome.

Next we screened all genomes for plasmid rep genes using PlasmidFinder [27], and identified six different rep genes that together were detected in ten (58.8%) isolate genomes (Fig 1). Among these, six isolates had only a single rep gene identified, while the remaining four had two or more rep genes. The E547 genome, belonging to ST2, encoded four different rep genes; this isolate also carried erythromycin and aminoglycoside resistance genes, which are often plasmid-encoded. While we did not observe any correlation between the rep families and the STs sampled, rep genes belonging to the rep9 family were detected in eight isolate genomes, making it the dominant rep family observed in this study.

We then assessed the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and their associated Cas loci, as well as the prophage content, of the 17 E. faecalis endophthalmitis genomes. Genomes were mined using CRISPRCasFinder [28] and PHASTER [19]. We observed that all the isolates in our study had identifiable CRISPR sequences, however E46, E139, E171, E474, and WGS406 encoded orphan CRISPR sequences without any associated Cas proteins (S3 Table). CRISPR sequences without adjacent Cas proteins have been previously observed in E. faecalis [29, 30]. The remaining 12 isolates did have Class 1 and/or Class 2 Cas proteins associated with their CRISPR loci (S3 Table, Fig 1). The five genomes lacking an intact CRISPR-Cas locus had more acquired antimicrobial resistance genes on average compared to CRISPR-Cas-positive genomes, but the difference was not statistically significant (mean 1.6 vs. 0.75 genes per genome, P = 0.09 by two-tailed t-test). Prophage analysis with PHASTER [19] detected intact or questionable prophages in 14/17 (82%) of the enterococcal genomes in this study. Prophages varied in size from 20–58.9Kb, and showed homology to previously described Enterococcus and other Gram-positive phages (S4 Table). We did not observe any correlation between CRISRP-Cas loci and the number of plasmid rep genes or prophages identified in the study isolate genomes.

Cytolysin activity

The E. faecalis cytolysin is a pore-forming toxin that lyses both bacterial and eukaryotic cells in response to quorum signals [3134]. We detected the cytolysin operon in 5/17 (29%) endophthalmitis isolate genomes (Fig 1). To confirm cytolysin operon activity, we tested the beta-hemolytic capacity of the 15 UPMC isolates on agar plates containing 5% horse blood. As predicted from their genomes, E46 (ST64), E171 (ST64), E286 (ST40) and E474 (ST103) showed beta-hemolysis when grown in the presence of horse blood [35]. We were unable to test for cytolysin activity in WGS406 because we only had access to the genome sequence of this strain.

Virulence-associated gene profiles and biofilm formation

We evaluated all 17 E. faecalis genomes for the presence of virulence-associated genes and operons using the VirulenceFinder database [36], along with manual searches for putative virulence gene sequences that have been previously described in E. faecalis [37] (S5 Table). We found that the fibronectin-binding proteins efbA and efaAfs, endocarditis and biofilm-associated pili ebpABC, sortase A (srtA), adhesin to collagen of E. faecalis (ace), general stress proteins gls24 and glsB, membrane metalloprotease associated with endocarditis (eep), thiol peroxidase for oxidative stress resistance (tpx), and sex pheromones cCF10, cOB1, cad and camE were present in the genomes of all isolates, with variable nucleotide identities (97–100% versus the reference sequence). Other virulence-associated genes were variably present, including the quorum-sensing gene fsrB, gelatinase gelE, serine protease sprE, hyaluronidase hylAB, and several genes often found within the E. faecalis pathogenicity island (PAI, S5 Table).

Biofilm formation is a well described pathogenicity-enhancing feature of many bacteria, including E. faecalis [38]. We measured the in vitro biofilm forming capacity of all 15 UPMC isolates using the crystal violet staining method [22], and observed differences in biofilm formation between isolates (Fig 2). These differences were not due to differences in bacterial growth rate, as there was no correlation between stationary phase optical density and biofilm formation among the tested isolates (S2 Fig). Isolate E286 (ST40) formed the most biofilm of any isolate tested, in contrast with the other two ST40 isolates, which formed only moderate biofilms (P<0.0001). Similarly, E171 (ST64) formed more biofilm than E46, another ST64 isolate (P<0.0001). Both ST2 isolates showed similar, moderate levels of biofilm formation, and the three ST122 isolates from the same patient were similar to one another in their ability to form biofilms, and were among the weakest biofilm formers of all the isolates tested.

Fig 2. Variable biofilm production among endophthalmitis isolates.

Fig 2

In vitro biofilm production of 15 E. faecalis endophthalmitis isolates. Biofilm formation was measured as the optical density (OD) at 550nm using a standard crystal violet-based assay. Isolates are arranged according to their sequence type (ST), and STs with more than one isolate are labeled. Bars shown mean crystal violet absorbance values, and error bars show standard deviation of triplicate experiments, each with eight technical replicates. NC = negative control; ****P<0.0001 by two-tailed t test; ns = not significant.

To identify candidate genes that might contribute to enhanced biofilm formation in E286 (ST40) and E171 (ST64), we examined the sequences of biofilm-associated genes between these isolates and other isolates of the same STs that formed weaker biofilms (S5 Table). The sequence of the collagen adhesin ace was intact in E286, but appeared to be disrupted in the other two ST40 isolates (S3 Fig). Separately, the genome of the E46 isolate, which formed less biofilm than the other ST64 isolate (E171), also had a disruption in the ace gene (S3 Fig). We also examined differences in gene content among the ST40 and ST64 isolates (S6 Table). Genes that were differentially present in E286 compared to E77 and E139 included prophage and plasmid-associated genes, while among the genes that were present in E171 but absent in E46 was an Asa373-like protein. This protein contains a BspA domain which has been previously associated with adhesion in Group B streptococci [39], and which has been shown to cause cell aggregation in E. faecalis [40].

Antimicrobial susceptibility phenotypes and correlation with genotypes

We investigated the antimicrobial susceptibilities of the 15 endophthalmitis isolates we collected by determining the minimum inhibitory concentrations (MICs) of six antibiotic and antiseptic compounds for all isolates (Table 1). All isolates were susceptible to vancomycin (MIC = 0.5–2 μg/mL), and all were inhibited by low concentrations of benzalkonium chloride and povidone-iodine. Larger susceptibility differences between isolates were observed for amikacin, ceftazidime, moxifloxacin, and ofloxacin. The genomes of the three isolates with the highest amikacin MICs (E374, E474, and E547) encoded aminoglycoside resistance genes (Fig 1). The same three isolates also showed higher MICs to both moxifloxacin and ofloxacin (Table 1). Enterococci are known to develop fluoroquinolone resistance via mutations in the genes encoding DNA gyrase subunit A (gyrA) and topoisomerase IV (parC) [2]. We examined the gyrA and parC sequences of the three fluoroquinolone-resistant isolates, and found that all three isolates encoded mutations at amino acid position 84 in gyrA and position 82 in parC (Table 2). The S84R and S84I mutations in gyrA and S82I mutation in parC have been described before [23, 41], and likely explain the fluoroquinolone resistance observed in these isolates. Finally, ceftazidime resistance was quite variable between isolates, with MICs ranging from 78.125–625μg/mL (Table 1). In general, isolates belonging to the same ST had similar ceftazidime susceptibilities, with MICs falling within two-fold of one another. The one exception was the three ST122 isolates, which were all isolated from the same patient [13]. The first two isolates from the patient (E616 and E623) had ceftazidime MICs of 78.125μg/mL, while the final isolate (E633) had an eight-fold higher MIC (MIC = 625μg/mL).

Table 1. Minimum Inhibitory concentration (MIC) profiles of E. faecalis endophthalmitis isolates.

Strain ID ST MIC (μg/mL)
AMK BKC CZA MOX OFX PI1 VAN
E374 2 512 2 312.5 16 32 0.31 1
E547 2 512 2 625 16 32 0.31 1
E266 25 128 2 156.25 0.25 4 0.31 0.5
E687 34 64 2 312.5 0.125 2 0.31 2
E77 40 128 2 312.5 0.25 2 0.31 2
E139 40 128 1 625 0.5 4 0.31 2
E286 40 64 2 625 0.5 2 0.31 2
E263 55 128 2 78.125 0.25 2 0.31 2
E46 64 64 2 312.5 0.25 2 0.31 1
E171 64 256 2 625 0.25 2 0.31 1
E474 103 512 2 312.5 32 32 0.31 1
E616 122 128 2 78.125 1 2 0.31 1
E623 122 128 2 78.125 1 4 0.31 1
E633 122 128 2 625 1 2 0.31 1
E676 428 128 2 1250 0.25 4 0.31 1

AMK = Amikacin, BKC = Benzalkonium Chloride, CZA = Ceftazidime, MOX = Moxifloxacin, OFX = Ofloxacin, PI = Povidone-iodine, VAN = Vancomycin

1Povidone-iodine MIC is reported as %.

Table 2. Amino acid substitutions in gyrA and parC identified in fluoroquinolone-resistant E. faecalis endophthalmitis isolates.

Isolate ID ST MXF MIC (μg/mL) Genotype
gyrA parC
E286 ST40 0.5 Wild type Wild type
E374 ST2 16 S84R S82I
E547 ST2 16 S84R S82I
E474 ST103 32 S84I S82I

Moxifloxacin (MXF); Minimum inhibitory concentration (MIC)

Emergence of reduced ceftazidime susceptibility in a hypermutator strain isolated from recurrent endophthalmitis

Whole-genome sequencing revealed that three E. faecalis isolates collected from a single patient with recurrent endophthalmitis were closely related to one another [13] (Fig 1). Using the first isolate from the patient (E616) as a reference, we looked for variants that arose in E623 (isolated 16 weeks after E616) and E633 (isolated 20 weeks after E616 and then grown in thioglycolate broth for three additional months before sequencing) [13]. We identified four variants in the E623 isolate genome compared to E616, including three small insertions and a non-synonymous mutation in a predicted arsenic resistance protein (S7 Table). The E633 isolate genome, in contrast, had 46 variants compared to E616 (S7 Table). Four of these were the same variants identified in E623, suggesting that E633 derived directly from E623. One of the new variants in E633 was a single base deletion in the DNA mismatch repair gene mutS, which was predicted to cause a frame-shift mutation at amino acid position 179 (S7 Table).

Mutations in mutS and mutL have been previously correlated with an increase in the rate of spontaneous mutation in E. faecalis [23]. To test whether the mutS mutation we observed was similarly associated with increased mutability, we quantified the rate of spontaneous mutation in E616, E623, and E633 using a rifampin mutagenicity assay (Fig 3). This assay has been used previously to quantify the spontaneous mutation rate in enterococci [23, 42]. The median spontaneous mutation rates of E616 and E623 were 6.3 x 10−9 and 7.5 x 10−9 respectively, while the mutation rate of E633 was over 100-fold higher at 1.3 x10-6 (Fig 3, P<0.0001). The increased mutation rate in E633 likely explains the excess of variants identified in this isolate, and may have also contributed to its decreased ceftazidime susceptibility and its ability to persist and cause a recurrent infection. Analysis of the variants accumulated by E633 versus E616 revealed that E633 carried mutations in genes encoding: (i) cell wall-associated proteins, such as a RodA-like rod-shape determining protein and a WxL domain-containing hypothetical protein, (ii) transcriptional regulators such as a LuxR two-component transcriptional response regulator and a Spx regulatory protein, and (iii) membrane-associated proteins such a putative serine/threonine exporter and a phosphotransferase system sugar transporter (S7 Table). Any of these, or additional variants identified in the E633 genome, might have contributed to the decreased cephalosporin susceptibility and persistence of this isolate in vivo.

Fig 3. An isolate from recurrent endophthalmitis with a mutation in the mismatch repair gene mutS has a higher spontaneous mutation rate compared to earlier isolates from the same patient.

Fig 3

Spontaneous mutation rate, measured with a rifampin mutagenicity assay, in isolates E616, E623 and E633, which were all sampled from a patient with recurrent endophthalmitis. Horizontal lines mark median values for results from 6 biological replicate experiments (each with 2–4 technical replicates).

Discussion

In this study, we characterized the genetic diversity and variability of antimicrobial susceptibility and virulence phenotypes among E. faecalis isolated from post-operative endophthalmitis. We found isolates belonging to well-known genetic lineages associated with clinical infections, as well as isolates resembling commensal enterococci lacking mobile genetic elements and other pathogenic traits. The presence of genetically diverse E. faecalis from endophthalmitis is in agreement with previous studies showing the absence of specific lineages that colonize the ocular environment [43]. The sequence types found in multiple endophthalmitis patients, however, included ST2, ST40, and ST64, which have all been previously found to cause infections [25]. A similarly diverse array of genetic lineages, with a subset being found more frequently, has also been observed in other Gram-positive bacteria isolated from ocular infections [44].

We found a high degree of variability in mobile genetic element content in the genomes of the isolates that we studied. The variable antimicrobial resistance genes we identified, including erm(B), tet(M), tet(S), ant(6)-Ia, aph(3′)-III, and aac(6’)-aph(2″), are among the most commonly observed resistance genes in E. faecalis [4547]. These resistance genes are often plasmid-encoded [48], and indeed nearly all genomes encoding acquired resistance genes also encoded one or more plasmid rep genes. Because we did not fully resolve the plasmid sequences in this study, however, we cannot formally connect resistance genes to the mobile elements carrying them. Cytolysin operon presence, CRISPR-Cas loci, and prophages were also variable among the E. faecalis we isolated. Similar to prior studies [49, 50], we detected more acquired antimicrobial resistance genes in the genomes of isolates lacking a functional CRISPR-Cas locus. The difference was not statistically significant, however, likely due to the limited number of genomes we sampled.

Virulence factors previously shown to contribute to enterococcal pathogenicity during endophthalmitis include the E. faecalis cytolysin [51], the fsr quorum-sensing system [52], and secreted proteases including gelatinase (GelE) and serine protease (SprE) [53]. Cytolysin operons were detected in only five of the 17 genomes analyzed here, while fsr quorum-sensing genes were detected in 13 genomes and GelE/SprE were detected in 16 genomes. Of the other virulence factors identified, some were found in all isolates while others were variably present, and when virulence genes were identified they often showed differences in nucleotide sequence compared to one another. Detailed clinical information about the patients these isolates were collected from was not available, thus we were unable to assess the relative severity of the infections. Examining correlations between virulence factors and clinical outcomes will be a focus of our future work.

The ability to form biofilms allows bacteria to persist at anatomical sites where they might normally be cleared. Biofilm formation on intraocular lenses has been suggested to contribute to bacterial endophthalmitis [54], and has been hypothesized to play a role in persistent and recurrent ocular infections [13, 55]. When we measured in vitro biofilm formation in the endophthalmitis isolates we collected, we observed differences across isolates, including isolates belonging to the same ST. Because same-ST isolates are often more closely related than isolates belonging to different STs, we examined the ST40 and ST64 isolate genomes for genetic differences that could account for increased biofilm formation, and focused our analysis on previously described biofilm and attachment factors. Disruption of the collagen adhesin gene ace was associated with diminished biofilm formation in both ST40 and ST64 isolates. Ace mediates E. faecalis adherence [56], and contributes to pathogenicity in animal models of infective endocarditis and urinary tract infection [57, 58]. We also identified an Asa373-like aggregation factor gene that was only present in the ST64 isolate that made more biofilm, and which is predicted to encode a surface adhesin that contributes to E. faecalis aggregation [40]. Further experiments such as targeted gene disruption or complementation would be required to validate the role of either one of these genes in biofilm formation; this will be a focus of our future work in this area.

Bacterial endophthalmitis is frequently managed by pre- and post-operative administration of topical or intravitreal antibiotics, often before identifying and testing the susceptibility of the organism [59, 60]. We observed differences in bacterial susceptibility to antibiotics between the isolates we tested, and in most cases, we were able to correlate increased MICs to resistance genes or resistance-associated mutations. All isolates were vancomycin susceptible, and all lacked Van operons. Aminoglycoside resistance genes were found in the isolates with the highest amikacin MICs, and previously described gyrA and parC mutations were found in the three fluoroquinolone-resistant isolates. While we observed variability in ceftazidime MICs between isolates, it is likely that multiple genes and/or mutations contribute to the intrinsic cephalosporin resistance that is common among enterococci. This was also apparent when considering the mutations present in the hypermutator isolate E633, which was less susceptible to ceftazidime compared to closely related isolates from the same patient collected at earlier infection time points. Although the E633 isolate genome encoded mutations in cell wall proteins, membrane proteins and transcriptional regulators, they were largely unrelated to known mechanisms of cephalosporin resistance such as the CroRS signal transduction pathway [61], the serine/threonine kinase IreK [62], and MurAA [63]. Overall, from these data we can conclude that vancomycin remains an appropriate treatment for suspected enterococcal endophthalmitis, however the availability of limited antibiotics for infection control and the use of aminoglycosides, cephalosporins, and fluoroquinolones could be ineffective due to pre-existing resistance in the infecting strain.

This study had several limitations. First, our sample size was quite small, as E. faecalis endophthalmitis is a relatively rare occurrence. In addition, the isolates we characterized were from a convenient sampling of strains available at the UPMC Eye Center, and detailed clinical information was not available for the patients that provided these isolates. Furthermore, our genomic analysis of virulence factors and correlations with biofilm production were restricted to the STs that were sampled from multiple patients and that showed within-ST differences in biofilm formation. Finally, we are unable to discern whether the mutS mutation we detected in the E633 isolate arose during recurrent endophthalmitis within the patient, or whether it was selected during the extended period of incubation after isolation. Further investigation is also needed to elucidate the mechanistic connection between genetic changes and increased ceftazidime resistance in the E633 isolate.

In summary, this study shows that E. faecalis causing post-operative endophthalmitis are genetically diverse and phenotypically variable. Our functional genomics analysis identified expected associations between antimicrobial resistance and biofilm formation genes, as well as the unexpected occurrence of a hypermutator isolate from a recurrent infection. Further work is needed to understand the precise contributions of enterococcal virulence factors such as Ace and Asa-373 to enterococcal growth in the collagen-rich vitreous humor, and to further elucidate the role of hypermutators in ocular infections. Such studies could lead to improved treatment strategies for intra-ocular infections, which would be welcome additions to an antimicrobial treatment arsenal that is under threat from increasing antibiotic resistance.

Supporting information

S1 Fig. Core genome phylogeny of 17 E. faecalis endophthalmitis isolates plus 49 diverse E. faecalis from the NCBI database.

A core genome alignment was generated for 1,710 core genes with Roary, and the phylogeny was made with RAxML. Tips are labeled with isolate name, source, sequence type (ST), and year of isolation. Isolates from endophthalmitis are labeled red. Bootstrap values >90 are shown on the tree.

(TIF)

S2 Fig. Biofilm staining versus stationary phase cell density of 15 E. faecalis endophthalmitis isolates.

Crystal violet OD550 values from a standard in vitro biofilm assay were compared with stationary phase OD600 values for the same isolates grown overnight in Brain Heart Infusion media supplemented with 0.25% glucose. The mean value for each isolate is plotted, and error bars indicate the standard error of the mean of 24 measurements for biofilm staining and 9 measurements for stationary phase cell density.

(TIF)

S3 Fig. Disruption of the ace collagen adhesin in isolates with reduced biofilm formation.

Nucleotide sequence alignment of the ace sequences from (A) ST40: E286, E77 and E139, and (B) ST64: E171 and E46 isolates. Yellow arrows show the ace coding sequence, black bars show nucleotide regions that align with one another, and black lines show deletions in isolates that form less biofilm.

(TIF)

S1 Table. Isolate information and UPMC genome assembly statistics.

(XLSX)

S2 Table. Publicly available E. faecalis isolates used for phylogenetic comparisons.

(XLSX)

S3 Table. CRISPR-cas loci in post-operative endophthalmitis E. faecalis genomes.

(XLSX)

S4 Table. Putative intact and questionable prophage encoding regions predicted by PHASTER.

(XLSX)

S5 Table. Enterococcal virulence factors present in E. faecalis endophthalmitis genomes.

(XLSX)

S6 Table. Variable gene presence/absence in ST40 and ST64 isolate genomes.

(XLSX)

S7 Table. Variants in recurrent endophthalmitis isolates (E623, E633) versus the earliest isolate from the same patient (E616).

(XLSX)

Acknowledgments

We gratefully acknowledge all members of the Van Tyne lab, and in particular Vatsala Srinivasa for assistance constructing the phylogeny shown in S1 Fig.

Data Availability

Illumina read data for isolates newly sequenced in this study have been submitted to NCBI under BioProject PRJNA649986. All other relevant data are within the paper and its Supporting Information files.

Funding Statement

This study was funded by PHS grant EY028222 to DVT and by the University of Pittsburgh Department of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Van Tyne D, Gilmore MS. Friend Turned Foe: Evolution of Enterococcal Virulence and Antibiotic Resistance. Annu Rev Microbiol. 2014;68: 337–356. 10.1146/annurev-micro-091213-113003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.García-Solache M, Rice LB. The Enterococcus: a Model of Adaptability to Its Environment. Clin Microbiol Rev. 2019;32: e00058–18. 10.1128/CMR.00058-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Fiore E, Van Tyne D, Gilmore MS. Pathogenicity of Enterococci. Microbiol Spectr. 2019;7: 10.1128/microbiolspec.GPP3-0053-2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kristich CJ, Rice LB, Arias CA. Enterococcal Infection—Treatment and Antibiotic Resistance. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection. Boston: Massachusetts Eye and Ear Infirmary; 2014; 2014. pp. 1–63. [Google Scholar]
  • 5.Price VJ, Huo W, Sharifi A, Palmer KL. CRISPR-Cas and Restriction-Modification Act Additively against Conjugative Antibiotic Resistance Plasmid Transfer in Enterococcus faecalis. Fey PD, editor. mSphere. 2016;1: e00064–16. 10.1128/mSphere.00064-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Noskin GA, Stosor V, Cooper I, Peterson LR. Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol. 1995;16: 577–581. 10.1086/647011 [DOI] [PubMed] [Google Scholar]
  • 7.Callegan MC, Engelbert M, Parke DW 2nd, Jett BD, Gilmore MS. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev. 2002;15: 111–124. 10.1128/cmr.15.1.111-124.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Melo GB, Bispo PJM, Yu MCZ, Pignatari ACC, Höfling-Lima AL. Microbial profile and antibiotic susceptibility of culture-positive bacterial endophthalmitis. Eye. 2011;25: 382–388. 10.1038/eye.2010.236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kuriyan AE, Sridhar J, Flynn HW, Smiddy WE, Albini TA, Berrocal AM, et al. Endophthalmitis Caused by Enterococcus faecalis: Clinical Features, Antibiotic Sensitivities, and Outcomes. Am J Ophthalmol. 2014;158: 1018–1023.e1. 10.1016/j.ajo.2014.07.038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Friling E, Lundström M, Stenevi U, Montan P. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg. 2013;39. 10.1016/j.jcrs.2012.10.037 [DOI] [PubMed] [Google Scholar]
  • 11.Kim JK, Nam KY, Chung IY, Jeung WJ, Kwon YH, Park JM, et al. Emerging Enterococcus isolates in postoperative endophthalmitis by selection pressure of fluoroquinolones: an 11-year multicenter and experimental study. Emerg Microbes Infect. 2020;9: 1892–1899. 10.1080/22221751.2020.1810134 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Teng YT, Teng MC, Kuo HK, Fang PC, Wu PC, Chen CH, et al. Isolates and antibiotic susceptibilities of endophthalmitis in postcataract surgery: a 12-year review of culture-proven cases. Int Ophthalmol. 2017;37: 513–518. 10.1007/s10792-016-0288-2 [DOI] [PubMed] [Google Scholar]
  • 13.Miller K V, Eisley KM, Shanks RMQ, Lahr RM, Lathrop KL, Kowalski RP, et al. Recurrent enterococcal endophthalmitis seeded by an intraocular lens biofilm. J Cataract Refract Surg. 2011;37: 1355–1359. 10.1016/j.jcrs.2011.04.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19: 455–477. 10.1089/cmb.2012.0021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30: 2068–2069. 10.1093/bioinformatics/btu153 [DOI] [PubMed] [Google Scholar]
  • 16.Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MTG, et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015/07/20. 2015;31: 3691–3693. 10.1093/bioinformatics/btv421 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014;30: 1312–1313. 10.1093/bioinformatics/btu033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Couvin D, Bernheim A, Toffano-Nioche C, Touchon M, Michalik J, Néron B, et al. CRISPRCasFinder, an update of CRISRFinder, includes a portable version, enhanced performance and integrates search for Cas proteins. Nucleic Acids Res. 2018;46: W246–W251. 10.1093/nar/gky425 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Arndt D, Grant JR, Marcu A, Sajed T, Pon A, Liang Y, et al. PHASTER: a better, faster version of the PHAST phage search tool. Nucleic Acids Res. 2016;44: W16–W21. 10.1093/nar/gkw387 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wiegand I, Hilpert K, Hancock REW. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3: 163–175. 10.1038/nprot.2007.521 [DOI] [PubMed] [Google Scholar]
  • 21.CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute. 2019.
  • 22.O’Toole GA. Microtiter Dish Biofilm Formation Assay. J Vis Exp. 2011; 2437. 10.3791/2437 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lieberman MT, Van Tyne D, Dzink-Fox J, Ma EJ, Gilmore MS, Fox JG. Long-Term Colonization Dynamics of Enterococcus faecalis in Implanted Devices in Research Macaques. Drake HL, editor. Appl Environ Microbiol. 2018;84: e01336–18. 10.1128/AEM.01336-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kirstahler P, Bjerrum SS, Friis-Møller A, la Cour M, Aarestrup FM, Westh H, et al. Genomics-Based Identification of Microorganisms in Human Ocular Body Fluid. Sci Rep. 2018;8: 4126. 10.1038/s41598-018-22416-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.McBride SM, Fischetti VA, Leblanc DJ, Moellering RC Jr, Gilmore MS. Genetic diversity among Enterococcus faecalis. PLoS One. 2007;2: e582–e582. 10.1371/journal.pone.0000582 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67: 2640–2644. 10.1093/jac/dks261 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Carattoli A, Zankari E, Garcia-Fernandez A, Voldby Larsen M, Lund O, Villa L, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58: 3895–3903. 10.1128/AAC.02412-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Grissa I, Vergnaud G, Pourcel C. CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats. Nucleic Acids Res. 2007/05/30. 2007;35: W52–W57. 10.1093/nar/gkm360 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Katyal I, Chaban B, Ng B, Hill JE. CRISPRs of Enterococcus faecalis and E. hirae Isolates from Pig Feces Have Species-Specific Repeats But Share Some Common Spacer Sequences. Microb Ecol. 2013;66: 182–188. 10.1007/s00248-013-0217-0 [DOI] [PubMed] [Google Scholar]
  • 30.Beukers AG, Zaheer R, Goji N, Amoako KK, Chaves A V, Ward MP, et al. Comparative genomics of Enterococcus spp. isolated from bovine feces. BMC Microbiol. 2017;17: 52. 10.1186/s12866-017-0962-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Eaton TJ, Gasson MJ. Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol. 2001;67: 1628–1635. 10.1128/AEM.67.4.1628-1635.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.De Vuyst L, Foulquie Moreno MR, Revets H. Screening for enterocins and detection of hemolysin and vancomycin resistance in enterococci of different origins. Int J Food Microbiol. 2003;84: 299–318. 10.1016/s0168-1605(02)00425-7 [DOI] [PubMed] [Google Scholar]
  • 33.Han D, Unno T, Jang J, Lim K, Lee S-N, Ko G, et al. The occurrence of virulence traits among high-level aminoglycosides resistant Enterococcus isolates obtained from feces of humans, animals, and birds in South Korea. Int J Food Microbiol. 2011;144: 387–392. 10.1016/j.ijfoodmicro.2010.10.024 [DOI] [PubMed] [Google Scholar]
  • 34.Van Tyne D, Martin MJ, Gilmore MS. Structure, function, and biology of the Enterococcus faecalis cytolysin. Toxins (Basel). 2013;5: 895–911. 10.3390/toxins5050895 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Coburn PS, Gilmore MS. The Enterococcus faecalis cytolysin: a novel toxin active against eukaryotic and prokaryotic cells. Cell Microbiol. 2003;5: 661–669. 10.1046/j.1462-5822.2003.00310.x [DOI] [PubMed] [Google Scholar]
  • 36.Joensen KG, Scheutz F, Lund O, Hasman H, Kaas RS, Nielsen EM, et al. Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli. J Clin Microbiol. 2014/02/26. 2014;52: 1501–1510. 10.1128/JCM.03617-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Freitas AR, Tedim AP, Novais C, Lanza VF, Peixe L. Comparative genomics of global optrA-carrying Enterococcus faecalis uncovers a common chromosomal hotspot for optrA acquisition within a diversity of core and accessory genomes. Microb genomics. 2020;6: 10.1099/mgen.0.000350 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ch’ng J-H, Chong KKL, Lam LN, Wong JJ, Kline KA. Biofilm-associated infection by enterococci. Nat Rev Microbiol. 2019;17: 82–94. 10.1038/s41579-018-0107-z [DOI] [PubMed] [Google Scholar]
  • 39.Rego S, Heal TJ, Pidwill GR, Till M, Robson A, Lamont RJ, et al. Structural and Functional Analysis of Cell Wall-anchored Polypeptide Adhesin BspA in Streptococcus agalactiae. J Biol Chem. 2016;291: 15985–16000. 10.1074/jbc.M116.726562 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Muscholl-Silberhorn A. Cloning and functional analysis of Asa373, a novel adhesin unrelated to the other sex pheromone plasmid-encoded aggregation substances of Enterococcus faecalis. Mol Microbiol. 1999;34: 620–630. 10.1046/j.1365-2958.1999.01631.x [DOI] [PubMed] [Google Scholar]
  • 41.Onodera Y, Okuda J, Tanaka M, Sato K. Inhibitory Activities of Quinolones against DNA Gyrase and Topoisomerase IV of Enterococcus faecalis. Antimicrob Agents Chemother. 2002;46: 1800 LP– 1804. 10.1128/aac.46.6.1800-1804.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Willems RJ, Top J, Smith DJ, Roper DI, North SE, Woodford N. Mutations in the DNA Mismatch Repair Proteins MutS and MutL of Oxazolidinone-Resistant or -Susceptible Enterococcus faecium. Antimicrob Agents Chemother. 2003;47: 3061 LP– 3066. 10.1128/aac.47.10.3061-3066.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Todokoro D, Eguchi H, Suzuki T, Suzuki M, Nakayama-Imaohji H, Kuwahara T, et al. Genetic diversity and persistent colonization of Enterococcus faecalis on ocular surfaces. Jpn J Ophthalmol. 2018;62: 699–705. 10.1007/s10384-018-0630-5 [DOI] [PubMed] [Google Scholar]
  • 44.Wurster JI, Bispo PJM, Van Tyne D, Cadorette JJ, Boody R, Gilmore MS. Staphylococcus aureus from ocular and otolaryngology infections are frequently resistant to clinically important antibiotics and are associated with lineages of community and hospital origins. PLoS One. 2018;13: e0208518–e0208518. 10.1371/journal.pone.0208518 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Roberts AP, Mullany P. A modular master on the move: the Tn916 family of mobile genetic elements. Trends Microbiol. 2009;17: 251–258. 10.1016/j.tim.2009.03.002 [DOI] [PubMed] [Google Scholar]
  • 46.Chow JW. Aminoglycoside Resistance in Enterococci. Clin Infect Dis. 2000;31: 586–589. 10.1086/313949 [DOI] [PubMed] [Google Scholar]
  • 47.Hidano A, Yamamoto T, Hayama Y, Muroga N, Kobayashi S, Nishida T, et al. Unraveling antimicrobial resistance genes and phenotype patterns among Enterococcus faecalis isolated from retail chicken products in Japan. PLoS One. 2015;10: e0121189–e0121189. 10.1371/journal.pone.0121189 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Hollenbeck BL, Rice LB. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence. 2012/08/15. 2012;3: 421–433. 10.4161/viru.21282 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Palmer KL, Gilmore MS. Multidrug-Resistant Enterococci Lack CRISPR. Losick R, editor. MBio. 2010;1: e00227–10. 10.1128/mBio.00227-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Price VJ, McBride SW, Hullahalli K, Chatterjee A, Duerkop BA, Palmer KL. Enterococcus faecalis CRISPR-Cas Is a Robust Barrier to Conjugative Antibiotic Resistance Dissemination in the Murine Intestine. Ellermeier CD, editor. mSphere. 2019;4: e00464–19. 10.1128/mSphere.00464-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Jett BD, Jensen HG, Nordquist RE, Gilmore MS. Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthalmitis. Infect Immun. 1992;60: 2445 LP– 2452. 10.1128/IAI.60.6.2445-2452.1992 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Mylonakis E, Engelbert M, Qin X, Sifri CD, Murray BE, Ausubel FM, et al. The Enterococcus faecalis fsrB gene, a key component of the fsr quorum-sensing system, is associated with virulence in the rabbit endophthalmitis model. Infect Immun. 2002;70: 4678–4681. 10.1128/iai.70.8.4678-4681.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Engelbert M, Mylonakis E, Ausubel FM, Calderwood SB, Gilmore MS. Contribution of gelatinase, serine protease, and fsr to the pathogenesis of Enterococcus faecalis endophthalmitis. Infect Immun. 2004;72: 3628–3633. 10.1128/IAI.72.6.3628-3633.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Wu M-C, Lin T-L, Hsieh P-F, Yang H-C, Wang J-T. Isolation of Genes Involved in Biofilm Formation of a Klebsiella pneumoniae Strain Causing Pyogenic Liver Abscess. Otto M, editor. PLoS One. 2011;6: e23500. 10.1371/journal.pone.0023500 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Teoh SCB, Lee J-J, Chee CKL, Au Eong K-G. Recurrent Enterococcus faecalis endophthalmitis after phacoemulsification. J Cataract Refract Surg. 2005;31: 622–626. 10.1016/j.jcrs.2004.06.047 [DOI] [PubMed] [Google Scholar]
  • 56.Nallapareddy SR, Qin X, Weinstock GM, Höök M, Murray BE. Enterococcus faecalis adhesin, ace, mediates attachment to extracellular matrix proteins collagen type IV and laminin as well as collagen type I. Infect Immun. 2000;68: 5218–5224. 10.1128/iai.68.9.5218-5224.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Singh K V, Nallapareddy SR, Sillanpää J, Murray BE. Importance of the collagen adhesin ace in pathogenesis and protection against Enterococcus faecalis experimental endocarditis. PLoS Pathog. 2010;6: e1000716. 10.1371/journal.ppat.1000716 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Lebreton F, Riboulet-Bisson E, Serror P, Sanguinetti M, Posteraro B, Torelli R, et al. ace, Which Encodes an Adhesin in Enterococcus faecalis, Is Regulated by Ers and Is Involved in Virulence. Infect Immun. 2009;77: 2832 LP– 2839. 10.1128/IAI.01218-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: An evidence-based update. Ophthalmology. 2002;109: 13–24. 10.1016/s0161-6420(01)00899-5 [DOI] [PubMed] [Google Scholar]
  • 60.Kishimoto T, Ishida W, Fukuda K, Nakajima I, Suzuki T, Uchiyama J, et al. Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis. Antimicrob Agents Chemother. 2019;63: e01088–19. 10.1128/AAC.01088-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Comenge Y, Quintiliani R, Li L, Dubost L, Brouard J-P, Hugonnet J-E, et al. The CroRS Two-Component Regulatory System Is Requiredfor Intrinsic β-Lactam Resistance in Enterococcusfaecalis. J Bacteriol. 2003;185: 7184 LP– 7192. 10.1128/jb.185.24.7184-7192.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Kristich CJ, Wells CL, Dunny GM. A eukaryotic-type Ser/Thr kinase in Enterococcus faecalis mediates antimicrobial resistance and intestinal persistence. Proc Natl Acad Sci. 2007;104: 3508 LP– 3513. 10.1073/pnas.0608742104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Kristich CJ, Little JL, Hall CL, Hoff JS. Reciprocal Regulation of Cephalosporin Resistance in Enterococcus faecalis. Low DE, editor. MBio. 2011;2: e00199–11. 10.1128/mBio.00199-11 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Iddya Karunasagar

10 Feb 2021

PONE-D-20-40363

Genomic and phenotypic diversity of Enterococcus faecalis isolated from endophthalmitis

PLOS ONE

Dear Dr. Van Tyne,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please provide information on nature of mutations leading to resistance and clinical outcomes in different cases.

Please submit your revised manuscript by Mar 26 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Iddya Karunasagar

Academic Editor

PLOS ONE

Additional Editor Comments:

The reviewers have made some suggestions. Some additional information suggested by reviewers will strenthen the manuscript. Please provide point to point response for the reviewer comments.

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This paper analyzed the genetic variation and phenotypic character of Enterococcus faecalis, which was identified as the causative agent of endophthalmitis, and reported its diversity. A total of 17 strains were used for the analysis, of which 15 were used at the center to which the author belongs, and 2 were reported. Whole genome sequences were analyzed and antibiotic susceptibility tests, biofilm and cytolysin assays, and genetic mutation assays were conducted to compare gene changes and phenotypic characteristics. Several experiments have shown quite good results, but the number of individuals is small, so it seems that it is not possible to draw a definite conclusion. However, infectious endophthalmitis occurs not only in one in tens of thousands of people, but also E. faecalis is less likely to occur as a causative agent. Recognizing these limitations, this paper can be seen as helpful in providing motives for various researches.

1. For the antibiotic resistance of fluoroquinolones, you have checked the mutation of gyrA. For parC, please describe how the mutation is. In fact, the reality is that there are few antibiotics available in eye clinic for infection control. Therefore, you may be more interested in antibiotic resistance to the first to fourth generations of fluoroquinolones, vancomycin, ceftazidime, cefuroxime, than other antibiotics. I hope that further research will be done on this.

2. E. faecalis, which is derived from endophthalmitis, can be very rare, but is relatively common in other diseases. Regarding this background, I think that comparing E. faecalis cultivated in other diseases can supplement the limitations of the paper.

3. Recently, there are papers that E. faecalis is increasing as a causative isolate of postoperative endophthalmitis. There are reports of these in Sweden, Taiwan, and Korea, and it would be nice to add them to the introduction.

Reviewer #2: This is an interesting, well-written, well-presented study of enterococcus samples that caused endophthalmitis at single institution. Known E. faecalis virulence factors (cytolysin and biofilm production) and antibiotic resistance genes in each genome were analyzed. Interestingly, the authors found evidence of E. faecalis adaptation during recurrent endophthalmitis by identifying genetic variants that arose in sequential isolates sampled at different time points from the same patient, however, it is not clear if the mutation arose during the recurrent endophthalmitis within the patient or if it was selected during the extended period of

incubation after isolation. All of the samples were susceptible to vancomycin.

While the variability in the virulence factors is interesting, it would be especially interesting to see if there was any clinical correlation between these virulence factors and outcomes.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Apr 14;16(4):e0250084. doi: 10.1371/journal.pone.0250084.r002

Author response to Decision Letter 0


2 Mar 2021

Point-by-point responses to the reviewer comments are included in the Response to Reviewers document. Other journal requirements have been addressed in the updated submission.

Attachment

Submitted filename: Response to reviewers_feb27.docx

Decision Letter 1

Iddya Karunasagar

31 Mar 2021

Genomic and phenotypic diversity of Enterococcus faecalis isolated from endophthalmitis

PONE-D-20-40363R1

Dear Dr. Van Tyne,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Iddya Karunasagar

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

All reviewer comments have been addressed satisfactorily

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: They answered the reviewer's question without any special problems. I think that it is practically inevitable to have a small number of E. faecalis bacteria isolated from postoperative endophthalmitis. I wonder if there is a possibility that the shortage of strains will be solved if international cooperative research is carried out.

Reviewer #2: The authors have addressed the comments. They are unable to make clinical correlations but identify it as a focus of future work.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Sang Joon Lee

Reviewer #2: No

Acceptance letter

Iddya Karunasagar

5 Apr 2021

PONE-D-20-40363R1

Genomic and phenotypic diversity of Enterococcus faecalis isolated from endophthalmitis

Dear Dr. Van Tyne:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Iddya Karunasagar

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Core genome phylogeny of 17 E. faecalis endophthalmitis isolates plus 49 diverse E. faecalis from the NCBI database.

    A core genome alignment was generated for 1,710 core genes with Roary, and the phylogeny was made with RAxML. Tips are labeled with isolate name, source, sequence type (ST), and year of isolation. Isolates from endophthalmitis are labeled red. Bootstrap values >90 are shown on the tree.

    (TIF)

    S2 Fig. Biofilm staining versus stationary phase cell density of 15 E. faecalis endophthalmitis isolates.

    Crystal violet OD550 values from a standard in vitro biofilm assay were compared with stationary phase OD600 values for the same isolates grown overnight in Brain Heart Infusion media supplemented with 0.25% glucose. The mean value for each isolate is plotted, and error bars indicate the standard error of the mean of 24 measurements for biofilm staining and 9 measurements for stationary phase cell density.

    (TIF)

    S3 Fig. Disruption of the ace collagen adhesin in isolates with reduced biofilm formation.

    Nucleotide sequence alignment of the ace sequences from (A) ST40: E286, E77 and E139, and (B) ST64: E171 and E46 isolates. Yellow arrows show the ace coding sequence, black bars show nucleotide regions that align with one another, and black lines show deletions in isolates that form less biofilm.

    (TIF)

    S1 Table. Isolate information and UPMC genome assembly statistics.

    (XLSX)

    S2 Table. Publicly available E. faecalis isolates used for phylogenetic comparisons.

    (XLSX)

    S3 Table. CRISPR-cas loci in post-operative endophthalmitis E. faecalis genomes.

    (XLSX)

    S4 Table. Putative intact and questionable prophage encoding regions predicted by PHASTER.

    (XLSX)

    S5 Table. Enterococcal virulence factors present in E. faecalis endophthalmitis genomes.

    (XLSX)

    S6 Table. Variable gene presence/absence in ST40 and ST64 isolate genomes.

    (XLSX)

    S7 Table. Variants in recurrent endophthalmitis isolates (E623, E633) versus the earliest isolate from the same patient (E616).

    (XLSX)

    Attachment

    Submitted filename: Response to reviewers_feb27.docx

    Data Availability Statement

    Illumina read data for isolates newly sequenced in this study have been submitted to NCBI under BioProject PRJNA649986. All other relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES